Market research
VLNS.TO The Valens Company Inc
TO CAD Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 82M
- P/E ratio
- Not available
- Analyst target
- 2.1
- Dividend yield
- 0.0%
- Beta
- 1.79
Profile
Company facts
- Exchange
- TO
- Currency
- CAD
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- ISIN
- CA91914P6030
- Market cap
- 82M
- P/E ratio
- Not available
- Analyst target
- 2.1
- Dividend yield
- 0.0%
- Beta
- 1.79
About
About The Valens Company Inc
The Valens Company Inc., through its subsidiaries, develops, manufactures, and sells cannabinoid-based products in Canada, the United States, and internationally. The company provides packaged dried flower/pre-rolls under the Verse, Versus, Contraband, and Citizen Stash brands; vapourizers and hydrocarbon extracts under the Verse and Versus brands; edible cannabis products under the Verse, Vacay, and LYF brands; and topical cannabis under the Nuance brand. It also offers analytical testing services to third party licensed producers in the cannabis space. The company is headquartered in Toronto, Canada. As of January 17, 2023, The Valens Company Inc. operates as a subsidiary of SNDL Inc.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the VLNS.TO discussion.
5 years, 5 months ago
The Valens Company Inc is currently in a long term uptrend where the price is trading 24.9% above its 200 day moving average.
From a valuation standpoint, the stock is 99.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.1.
The Valens Company Inc's total revenue sank by 47.6% to $16M since the same quarter in the previous year.
Its net income has dropped by 472.4% to $-17M since the same quarter in the previous year.
Finally, its free cash flow grew by 97.5% to $-599K since the same quarter in the previous year.
Based on the above factors, The Valens Company Inc gets an overall score of 3/5.